LixiLan-G: A Randomized Trial Assessing Switching to iGlarLixi vs. Continuation of Daily or Weekly GLP-1RA in T2D Inadequately Controlled by a GLP-1RA and OAD(s)

Category Primary study
JournalDIABETES
Year 2019
This article has no abstract
Epistemonikos ID: 3ea801971d199a661ffbf8866f62138008135fe4
First added on: Feb 11, 2025